Engdahl E, et al. Serological response against HHV-6A is associated with increased risk for multiple sclerosis. Abstract 222. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
TOP-subsidie voor onderzoek naar vroege hersenafwijkingen Alzheimer
feb 2019 | Dementie